Richard Lehman’s journal review – 7 February 2011

JAMA  2 Feb 2011  Vol 305 487   Most of us have never come near a vial of bevacizumab, though we’ve read plenty about it, especially over recent years in the context of eye disease involving vascular proliferation. This monoclonal antibody targeting vascular endothelial growth factor A was initially developed as a treatment for solid cancers […]

Read More…

Research highlights – 4 February 2011

“Research highlights” is a weekly round-up of research papers appearing in the print BMJ. We start off with this week’s research questions, before providing more detail on some individual research papers and accompanying articles How effective are two risk stratification schemes at predicting thromboembolic events in patients with atrial fibrillation? Is CPR with chest compression […]

Read More…

Richard Lehman’s journal review – 31 January 2011

JAMA  26 Jan 2011  Vol 305 391   Stroke medicine grew up in the 1990s: like heart failure medicine, it shone welcome light on a large and neglected group of patients with organ damage who had been written off as unsalvageable. This was a Very Good Thing in itself, but its proponents then went on to […]

Read More…

Research highlights – 28 January 2011

“Research highlights” is a weekly round-up of research papers appearing in the print BMJ. We start off with this week’s research questions, before providing more detail on some individual research papers and accompanying articles. Does vitamin D supplementation improve bone mineral density in healthy children? What are the perspectives of people living and dying with […]

Read More…

Research highlights – 21 January 2011

“Research highlights” is a weekly round-up of research papers appearing in the print BMJ. We start off with this week’s research questions, before providing more detail on some individual research papers and accompanying articles. What is the association between headaches and volume of white matter hyperintensities on magnetic resonance imaging of the brain? What are […]

Read More…

Richard Lehman’s journal review, 10 January 2011

JAMA 5 Jan 2011 Vol 305 43 Implantable cardioverter-defibrillators are a good intervention for those who have bad systolic heart failure with a risk of ventricular arrhythmia, and would rather die slowly than suddenly. The “utility” of the device is that it can have a statistically significant effect on mortality in younger, properly selected patients; […]

Read More…

Richard Lehman’s journal review, 4 January 2011

NEJM  30 Dec 2010  Vol 363 2588   A sizeable multinational study seeks to find out whether providing free daily anti-retroviral drugs as well as free condoms might help to reduce the transmission of human immunodeficiency virus in men who have sex with men. The majority of the subjects were recruited in Peru, with smaller groups […]

Read More…

Richard Lehman’s journal review – 29 December 2010

JAMA  22-29 Dec 2010 Vol 304 2732   “Professionalism may not be sufficient to drive the profound and far-reaching changes needed in the care system, but without it, the health care enterprise is lost.” Britons, take heed! This “special communication” was written by a social scientist and five doctors to inform the debate about American health […]

Read More…